Published : 2022-10-14 11:56:13
Categories : Press Releases
Nyon, Switzerland, 4 October 2022 - Horus Pharma, an independent French laboratory specialized in ophthalmology, has taken the next step in its European expansion strategy with the creation of a new subsidiary – Horus Pharma Switzerland.
Horus Pharma International, established in 2010, is a Swiss based entity in charge of international distribution for the Group. Horus Pharma’s preservative-free eye and eyelid care products have been available in Switzerland since local distribution contracts were signed via a partnership agreement. Over the past years local players’ and consumers’ confidence in the products has increased as has Horus Pharma’s knowledge of the Swiss market. This is why Horus Pharma has decided to establish Horus Pharma Switzerland in Nyon, in Vaud as a component of its European expansion strategy.
Nicolas Claret, Managing Director of Horus Pharma Switzerland: “We are delighted that from September 2022 we can begin offering our full range of eye drops and medical devices to Swiss patients and healthcare professionals through Horus Pharma Switzerland.
“Horus Pharma’s full range of products includes medical devices, such as Neovis® Total, Vitreal S and ODM5®, the Ilast® dermato-cosmetic range. It also includes an innovative range of surgical and peri-surgical solutions that will soon be available on the Swiss market.”
Horus Pharma, founded in 2003, is an independent laboratory and key player in ophthalmology in Europe. The Company’s deeply-rooted values of passion, commitment and ethics reflect its primary objective - to improve the daily lives of patients affected by eye diseases by offering effective and practical solutions. This is why innovation is one of the main drivers of the Company’s Research & Development policy. Horus Pharma is renowned for its expertise in developing preservative-free products.
Horus Pharma distributes its products throughout France from its headquarters in Saint-Laurent du Var near Nice, in Belgium, the Netherlands, Luxembourg, Spain and now Switzerland through subsidiaries, and in many other countries through distribution agreements.